197 related articles for article (PubMed ID: 31538590)
1. Docosahexaenoic Acid and Arachidonic Acid Supplementation and Sleep in Toddlers Born Preterm: Secondary Analysis of a Randomized Clinical Trial.
Boone KM; Rausch J; Pelak G; Li R; Turner AN; Klebanoff MA; Keim SA
J Clin Sleep Med; 2019 Sep; 15(9):1197-1208. PubMed ID: 31538590
[TBL] [Abstract][Full Text] [Related]
2. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic and Arachidonic Acid Supplementation of Toddlers Born Preterm Does Not Affect Short-Term Growth or Adiposity.
Ingol TT; Li R; Boone KM; Rausch J; Klebanoff MA; Turner AN; Yeates KO; Nelin MA; Sheppard KW; Keim SA
J Nutr; 2019 Dec; 149(12):2182-2190. PubMed ID: 31187863
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acid Supplementation and Socioemotional Outcomes: Secondary Analysis of a Randomized Trial.
Boone KM; Parrott A; Rausch J; Yeates KO; Klebanoff MA; Norris Turner A; Keim SA
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32887793
[TBL] [Abstract][Full Text] [Related]
5. Effects of Omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomized clinical trial.
Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Keim SA
Early Hum Dev; 2022 Jun; 169():105588. PubMed ID: 35644107
[TBL] [Abstract][Full Text] [Related]
6. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
[TBL] [Abstract][Full Text] [Related]
9. ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers.
Keim SA; Gracious B; Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Sheppard KW; Husk J; Rhoda DA
J Nutr; 2018 Feb; 148(2):227-235. PubMed ID: 29490101
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial.
Boone KM; Gracious B; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Keim SA
Early Hum Dev; 2017 Dec; 115():64-70. PubMed ID: 28941976
[TBL] [Abstract][Full Text] [Related]
11. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
12. Growth, metabolic markers, and cognition in 8-year old children born prematurely, follow-up of a randomized controlled trial with essential fatty acids.
Henriksen C; Almaas AN; Westerberg AC; Drevon CA; Iversen PO; Nakstad B
Eur J Pediatr; 2016 Sep; 175(9):1165-1174. PubMed ID: 27502791
[TBL] [Abstract][Full Text] [Related]
13. Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial.
Kerling EH; Hilton JM; Thodosoff JM; Wick J; Colombo J; Carlson SE
JAMA Netw Open; 2019 Feb; 2(2):e190088. PubMed ID: 30794304
[TBL] [Abstract][Full Text] [Related]
14. Randomized Controlled Trial of Early Docosahexaenoic Acid and Arachidonic Acid Enteral Supplementation in Very Low Birth Weight Infants.
Frost BL; Patel AL; Robinson DT; Berseth CL; Cooper T; Caplan M
J Pediatr; 2021 May; 232():23-30.e1. PubMed ID: 33358843
[TBL] [Abstract][Full Text] [Related]
15. Effect of arachidonic and docosahexaenoic acid supplementation on quality of growth in preterm infants: A secondary analysis of a randomized controlled trial.
Rossholt ME; Bratlie M; Wendel K; Aas MF; Gunnarsdottir G; Fugelseth D; Pripp AH; Domellöf M; Størdal K; Stiris T; Moltu SJ
Clin Nutr; 2023 Dec; 42(12):2311-2319. PubMed ID: 37856920
[TBL] [Abstract][Full Text] [Related]
16. Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes and neonatal morbidities in preterm infants.
Wendel K; Aas MF; Gunnarsdottir G; Rossholt ME; Bratlie M; Nordvik T; Landsend ECS; Fugelseth D; Domellöf M; Pripp AH; Stiris T; Moltu SJ
Clin Nutr; 2023 Jan; 42(1):22-28. PubMed ID: 36473425
[TBL] [Abstract][Full Text] [Related]
17. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial.
Sjöbom U; Andersson MX; Pivodic A; Lund AM; Vanpee M; Hansen-Pupp I; Ley D; Wackernagel D; Sävman K; Smith LEH; Löfqvist C; Hellström A; Nilsson AK
Clin Nutr; 2023 Jun; 42(6):962-971. PubMed ID: 37120902
[TBL] [Abstract][Full Text] [Related]
18. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
19. Effect of Maternal Docosahexaenoic Acid Supplementation on Very Preterm Infant Growth: Secondary Outcome of a Randomized Clinical Trial.
Angoa G; Pronovost E; Ndiaye ABKT; Lavoie PM; Lemyre B; Mohamed I; Simonyan D; Qureshi M; Afifi J; Yusuf K; Sériès T; Guillot M; Piedboeuf B; Fraser WD; Nuyt AM; Mâsse B; Lacaze-Masmonteil T; Marc I
Neonatology; 2022; 119(3):377-385. PubMed ID: 35413719
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
